環球醫療(02666.HK)附屬重組及進一步增資
環球醫療(02666.HK)公布,於8月31日全資附屬醫投公司與新五礦系投資方、現有五礦系投資方、五礦創投、中信資本及目標公司通用五礦醫院管理共同簽署了一項重組協議,簽約方約定重組目標醫療機構並向目標公司進一步增資。
醫投公司、五礦創投及中信資本將分別以現金形式向目標公司增資8.92億元人民幣(下同)、9,700萬元及1.94億元,新五礦系投資方將以注入目標資產的形式向目標公司實物出資7.57億元。
重組完成後,目標公司將分別由醫投公司持股46%、五礦系投資方持股39%、五礦創投持股5%及中信資本持股10%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.